Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	4.18B -39.6%
Revenue (ttm)	6.75B +8.7%
Net Income	364.62M +1.7%
EPS	4.29 +1.7%
Shares Out	85.00M
PE Ratio	11.47
Forward PE	11.33
Dividend	2.52 (5.05%)
Ex-Dividend Date	Feb 11, 2026

Volume	224,465
Average Volume	170,393
Open	49.52
Previous Close	49.92
Day's Range	48.98 - 49.68
52-Week Range	48.70 - 87.30
Beta	0.09
RSI	36.80
Earnings Date	Mar 16, 2026

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on beh...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Employees: 6,014
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2024, TADAWUL:4163's revenue was 6.45 billion, an increase of 12.36% compared to the previous year's 5.74 billion. Earnings were 370.11 million, an increase of 12.42%.